Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ENGENE HOLDINGS INC *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | 2,427 | 1,728 | 0.42% | -699 |
| ACHILLES THERAPEUTICS PLC | 2,390,050 | 0 | -2,390,050 | 2,749 | 0 | — | -2,749 |
| ASTRIA THERAPEUTICS INC | 2,872,537 | 3,822,537 | +950,000 | 25,680 | 20,412 | 4.93% | -5,268 |
| REPLIMUNE GROUP INC(REPL) | 3,970,668 | 3,909,696 | -60,972 | 48,085 | 38,120 | 9.21% | -9,965 |
| BICYCLE THERAPEUTICS PLC | 3,452,330 | 3,452,330 | 0 | 48,333 | 29,310 | 7.08% | -19,022 |
| ENGENE HOLDINGS INC COM | 9,632,561 | 9,632,561 | 0 | 64,057 | 43,154 | 10.43% | -20,903 |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 10,597,181 | 10,935,310 | +338,129 | 272,348 | 223,846 | 54.11% | -48,502 |
| DYNE THERAPEUTICS INC(DYN) | 5,462,846 | 5,462,846 | 0 | 128,705 | 57,141 | 13.81% | -71,563 |